SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 31.86+0.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: aknahow who wrote (6811)7/26/1998 6:58:00 PM
From: Tharos  Read Replies (2) of 17367
 
>>Wall Street hates any company it has invested in that has a drug failure. Wall Street does not care that an oil company almost went broke with a string of dry exploration wells if an important big hit has just been made. The past is just so much useless history. If a bad luck biotech hits it big with an approval, Wall Street will be there.<<

As you, and any other market student for that matter, know, Wall Street is fickle. It is the in-efficient market that allows contrarian investors to make money. The contrarian's water is deeper and more sharks are in it, giving a greater potential for the casual investor to lose money. But for those willing to study carefully and be patient, the rewards are emotionally and statistically greater than "buy and hold." I am speaking of the pride of being involved in bringing a new product to market, and of earning an above average return on your money while doing it.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext